← Back to Patent Explorer
US5338291A Expired / Lapsed US ⏱️ 0.0 years remaining

Glaucoma shunt and method for draining aqueous humor

Assignee: Medtronic Inc
•
Filing: 1993-02-03
•
Granted: 1994-08-16
•
Expires: 2013-02-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An implantable shunt device useful in treating glaucoma includes an episcleral plate and a catheter having a first end adapted for insertion into the anterior chamber of the eye, and a second end mounted adjacent to the episcleral plate. A slit valve is provided in a wall of the catheter between the first end and the second end, and the opposing, generally planar surfaces of the episcleral plate are textured to interrupt the formation of a dense fibrous capsule and to promote vascularization around the episcleral plate. In order to restrict the flow of fluid through the catheter to the episcleral plate until a fibrous capsule forms around the episcleral plate, the catheter is temporarily occluded utilizing a biodegradable ligation tied between the slit valve and the second end of the catheter. In the immediate post-operative period, excess aqueous humor is forced to flow through the slit valve, which provides a significant pressure drop. Once the ligature is resorbed, aqueous humor is free to flow through the catheter to the episcleral plate for resorption into the vascular system.

Inventors

  • 👤 Lori C. Speckman
  • 👤 David A. Watson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 08:08
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/00781

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 108 words
An implantable shunt device useful in treating glaucoma, comprising: an episcleral plate having first and second surfaces, wherein at least one of the first and second surfaces includes texture means over substantially the entire surface thereof, for preventing excess fibrosis of a fibrous capsule forming around the episcleral plate; a catheter having a first end adapted for insertion into the anterior chamber of the eye, and a second end mounted adjacent to the episcleral plate; and a valve in a wall of the catheter, between the first end and the second end of the catheter to shunt fluid within the catheter to a location exterior of the catheter.
Claim 2
Dependent Claim 108 words
An implantable shunt device useful in treating glaucoma, comprising: an episcleral plate having first and second surfaces, wherein at least one of the first and second surfaces includes texture means over substantially the entire surface thereof, for preventing excess fibrosis of a fibrous capsule forming around the episcleral plate; a catheter having a first end adapted for insertion into the anterior chamber of the eye, and a second end mounted adjacent to the episcleral plate; and a valve in a wall of the catheter, between the first end and the second end of the catheter to shunt fluid within the catheter to a location exterior of the catheter.
Claim 3
Dependent Claim 55 words
A shunt device as set forth in claim 1, wherein the texture means comprises a plurality of fingers extending outwardly from the episcleral plate, the fingers being spaced along the surface approximately 0.018 inch center to center from one another, and having dimensions of approximately 0.010 inch in width and approximately 0.011 inch in height.
Claim 4
Dependent Claim 28 words
A shunt device as set forth in claim 1, wherein the episcleral plate has a spherical arch-shape to match the shape of a posterior portion of the eye.
Claim 5
Dependent Claim 19 words
A shunt device as set forth in claim 1, including means for attaching the episcleral plate to the sclera.
Claim 6
Dependent Claim 16 words
A shunt device as set forth in claim 1, wherein the valve comprises a slit valve.
Claim 7
Dependent Claim 20 words
(Amended) A shunt device as set forth in claim 5, including graphite applied to opposing faces of the slit valve.
Claim 8
Dependent Claim 33 words
A shunt device as set forth in claim 1, including means for restricting the flow of fluid through the catheter to the episcleral plate until the fibrous capsule forms around the episcleral pate.
Claim 9
Dependent Claim 27 words
A shunt device as set forth in claim 7, wherein the restricting means comprises a biodegradable ligature between the valve and the second end of the catheter.
Claim 10
Dependent Claim 94 words
An implantable shunt device useful in treating glaucoma, comprising: an episcleral plate; a single-lumen catheter having a first end adapted for insertion into the anterior chamber of the eye, and a second end mounted adjacent to the episcleral plate; a valve in a wall of the catheter, situated between the first end and the second end of the catheter, for shunting fluid from the catheter lumen exteriorly of the catheter; and means for restricting the flow of fluid through the catheter to the episcleral plate until a fibrous capsule forms around the episcleral plate.
Claim 11
Dependent Claim 94 words
An implantable shunt device useful in treating glaucoma, comprising: an episcleral plate; a single-lumen catheter having a first end adapted for insertion into the anterior chamber of the eye, and a second end mounted adjacent to the episcleral plate; a valve in a wall of the catheter, situated between the first end and the second end of the catheter, for shunting fluid from the catheter lumen exteriorly of the catheter; and means for restricting the flow of fluid through the catheter to the episcleral plate until a fibrous capsule forms around the episcleral plate.
Claim 12
Dependent Claim 63 words
A shunt device as set forth in claim 9, including means for interrupting the formation of a dense fibrous capsule around the episcleral plate, the interrupting means including a first textured surface on the episcleral plate and a second textured surface on the episcleral plate, wherein the first and second surfaces each comprise a plurality of fingers extending outwardly from the episcleral plate.
Claim 13
Dependent Claim 39 words
A shunt device as set forth in claim 9, including means for attaching the episcleral plate to the sclera, and wherein the episcleral plate has a spherical arch-shape to match the shape of a posterior portion of the eye.
Claim 14
Dependent Claim 44 words
A shunt device as set forth in claim 9, wherein the valve comprises a slit valve and includes means for preventing adhesion between opposing faces of the slit valve, the adhesion preventing means including graphite applied to the opposing faces of the slit valve.
Claim 15
Dependent Claim 27 words
A shunt device as set forth in claim 9, wherein the restricting means comprises a biodegradable ligature between the valve and the second end of the catheter.
Claim 16
Dependent Claim 45 words
A shunt device as set forth in claim 9, wherein the episcleral plate includes first and second surfaces, and wherein at least one of the first and second surfaces includes texture means for preventing excess fibrosis of a fibrous capsule forming around the episcleral plate.
Claim 17
Dependent Claim 32 words
A shunt device as set forth in claim 14, wherein the texture means extends over substantially over the entire surface area of the at least one of the first and second surfaces.
Claim 18
Dependent Claim 55 words
A shunt device as set forth in claim 14, wherein the texture means comprises a plurality of fingers extending outwardly from the episcleral plate, the fingers being spaced along the surface approximately 0.018 inch center to center from one another, and having dimensions of approximately 0.010 inch in width and approximately 0.011 inch in height.
Claim 19
Independent Claim 127 words
A method for treating glaucoma with a surgically implantable device, the steps comprising: inserting a first end of a catheter into the anterior chamber of the eye; securing a plate, connected to a second end of the catheter, to the sclera of the eye; providing a slit valve in a wall of the catheter between the first end and the second end thereof; restricting the flow of fluid through the catheter to the plate upon implantation of the surgically implantable device by ligating the catheter between the slit valve and the second end of the catheter; and non-surgically removing, gradually over an extended length of time, the restriction on the flow of fluid through the catheter to the plate after a fibrous capsule forms around the plate.
Claim 20
Independent Claim 127 words
A method for treating glaucoma with a surgically implantable device, the steps comprising: inserting a first end of a catheter into the anterior chamber of the eye; securing a plate, connected to a second end of the catheter, to the sclera of the eye; providing a slit valve in a wall of the catheter between the first end and the second end thereof; restricting the flow of fluid through the catheter to the plate upon implantation of the surgically implantable device by ligating the catheter between the slit valve and the second end of the catheter; and non-surgically removing, gradually over an extended length of time, the restriction on the flow of fluid through the catheter to the plate after a fibrous capsule forms around the plate.
Claim 21
Dependent Claim 23 words
A method as set forth in claim 17, including the step of dissolving the ligation after a fibrous capsule forms around the plate.
Claim 22
Dependent Claim 26 words
A method as set forth in claim 17, including the steps of interrupting the formation of a dense fibrous capsule and promoting vascularization around the plate.
Claim 23
Dependent Claim 24 words
A method as set forth in claim 19, wherein the interrupting step includes the step of providing a non-planar surface texture to the plate.

References Cited (Backward Citations)

US3159161A Cited
US4521210A Cited
US4729761A Cited
GB2187963A Cited
US4722724A Cited
US4767400A Cited
US4968296A Cited
WO1991012037A1 Cited
US5178604A Cited
US5171213A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-08-15 1998-02-14 1998-08-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-08-15 2002-02-14 2002-08-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-08-15 2006-02-14 2006-08-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag